StockData
Arvinas, Inc. logo

Arvinas, Inc. (ARVN) stock

ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$6.76−0.06 (-0.81%)

Close on Nov 18, 2026Market cap $442.34MP/E 42.3Yield –

Arvinas price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Arvinas's price to book ratio was 0.8× on Nov 11, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 0.8× to 5.3×, with a median of 2.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.8×−0.7
2025Dec 31, 20251.5×−0.8
2024Dec 31, 20242.2×−2.7
2023Dec 29, 20235.0×+2.0
2022Dec 30, 20222.9×−2.4
2021Dec 31, 20215.3×−11.3
2020Dec 31, 202016.6×+6.5
2019Dec 31, 201910.1×–

More Arvinas figures

See a number that looks wrong?